Stem cell and PRP injections for knee arthritis: what the trials show

Why knees are different from many other claims

Much of what is written about stem cells rests on laboratory studies, animal work and uncontrolled case series. Knee osteoarthritis is the exception: it has large, randomized trials with proper comparison groups. That means we can move beyond “it may help” to what actually happened when these injections were tested fairly.

What the stem cell trials show

The largest trial so far randomized 480 adults with knee osteoarthritis to bone marrow aspirate concentrate, fat-derived cells, umbilical-cord-derived cells or a corticosteroid injection. At 12 months, none of the cell products outperformed the steroid on pain or function.¹

Smaller early-phase trials of umbilical-cord mesenchymal stromal cells have reported better pain scores than hyaluronic acid with repeated dosing,² but trials of that size are designed to test safety and signals, not to establish that an injection works.

What the PRP trials show

PRP for knee osteoarthritis has been studied in many randomized trials, often against hyaluronic acid, with a number reporting modest benefits. The largest placebo-controlled trial, RESTORE, randomized 288 people to PRP or saline: at 12 months there was no difference in pain or in cartilage volume on MRI.³ Differences in PRP preparation between studies make the overall picture genuinely mixed.

What guidelines recommend

The American College of Rheumatology and Arthritis Foundation strongly recommend exercise, weight management (when relevant), tai chi and other self-management for knee osteoarthritis, and recommend against PRP and stem cell injections.⁴ In the IDEA trial, overweight adults with knee osteoarthritis who combined diet and exercise lost about 10% of body weight and had greater pain reduction than exercise alone at 18 months.⁵ For patients who carry extra weight, physician-led weight management is often one of the most effective things we can offer a painful knee.

Who may still reasonably consider an injection

Evidence at the population level does not dictate every individual decision. After a full evaluation, a regenerative injection may be a reasonable, informed choice for someone who:

• has mild-to-moderate osteoarthritis on X-ray rather than bone-on-bone disease;
• has tried structured exercise, weight management where relevant and conventional options;
• wants to avoid or delay surgery and understands that a procedure may not change that path;
• understands that cell-based products are not FDA-approved and results are uncertain, and has signed the Florida disclosure and consent;
• can afford the cost without strain.

Patients with advanced arthritis, mechanical locking from a displaced meniscus tear, active infection or inflammatory arthritis flares usually need a different plan. See knee, hip and shoulder pain.

Other options for knee arthritis

• Exercise and physical therapy — quadriceps and hip strengthening, gait and load management.
• Weight management — including GLP-1 medication for eligible patients.
• Medication — topical and oral anti-inflammatories where safe.
• Corticosteroid injection — short-term relief for flares.
• Bracing and activity modification.
• Surgical opinion — for advanced disease or mechanical problems.

If you and your physician decide to proceed

At PrimeCell the sequence is: evaluation and imaging review; written disclosure, consent and estimate; an ultrasound-guided injection performed by Dr. Chantasi when appropriate; a few days of soreness and reduced activity; then a structured rehabilitation plan and follow-up. Any improvement tends to develop over weeks to months, and may not occur. Your pain and function scores are tracked in PrimeCell’s Outcomes Follow-Up program.